Low‐Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.033700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Ying Peng und 20 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cardiovascular Diseases, Henan Key Laboratory of Hereditary Cardiovascular Diseases The First Affiliated Hospital of Zhengzhou University,…. Hauptthemen laut MEDLINE: Colchicine, Doxorubicin, Cardiotoxicity, Autophagy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The only clinically approved drug that reduces doxorubicin cardiotoxicity is dexrazoxane, but its application is limited due to the risk of secondary malignancies. So, exploring alternative effective molecules to attenuate its cardiotoxicity is crucial. Colchicine is a safe and well‐tolerated drug that helps reduce the production of reactive oxygen species. High doses of colchicine have been reported to block the fusion of autophagosomes and lysosomes in cancer cells. However, the impact of colchicine on the autophagy activity within cardiomyocytes remains inadequately elucidated. Recent studies have highlighted the beneficial effects of colchicine on patients with pericarditis, postprocedural atrial fibrillation, and coronary artery disease. It remains ambiguous how colchicine regulates autophagic flux in doxorubicin‐induced heart failure. Methods and Results Doxorubicin was administered to establish models of heart failure both in vivo and in vitro. Prior studies have reported that doxorubicin impeded the breakdown of autophagic vacuoles, resulting in damaged mitochondria and the accumulation of reactive oxygen species. Following the administration of a low dose of colchicine (0.1 mg/kg, daily), significant improvements were observed in heart function (left ventricular ejection fraction: doxorubicin group versus treatment group=43.75%±3.614% versus 57.07%±2.968%, P =0.0373). In terms of mechanism, a low dose of colchicine facilitated the degradation of autolysosomes, thereby mitigating doxorubicin‐induced cardiotoxicity.
Conclusions
Our research has shown that a low dose of colchicine is pivotal in restoring the autophagy activity, thereby attenuating the cardiotoxicity induced by doxorubicin. Consequently, colchicine emerges as a promising therapeutic candidate to improve doxorubicin cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cardiovascular Diseases, Henan Key Laboratory of Hereditary Cardiovascular Diseases The First Affiliated Hospital of Zhengzhou University, Zhengzhou University Zhengzhou China.
- Department of Cardiology, Beijing Anzhen Hospital Capital Medical University Beijing China.
- CAS Key Laboratory of Infection and Immunity, Institute of Biophysics Chinese Academy of Sciences Beijing China.
- Department of Neurology The First Affiliated Hospital of Zhengzhou University, Zhengzhou University Zhengzhou China.
- Centre for Cancer Biomarkers & Biotherapeutics Barts Cancer Institute, Queen Mary University of London London United Kingdom.
ORCID-Profile: Ying Peng, Yiming Dong, Yangyang Liu, Liping Sun, Hailong Tao, Deyong Long, Xiaoyan Zhao, Xin Du, Changsheng Ma, Yaohe Wang, Jianzeng Dong
Zitieren
APA
Peng, Y., Li, Z., Zhang, J., Dong, Y., Zhang, C., Dong, Y., Zhai, Y., Zheng, H., Liu, M., Zhao, J., Du, W., Liu, Y., Sun, L., Li, X., Tao, H., Long, D., Zhao, X., Du, X., Ma, C., …, & Dong, J. (2024). Low‐Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033700
Vancouver
Peng Y, Li Z, Zhang J, Dong Y, Zhang C, Dong Y, et al. Low‐Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.033700
BibTeX
@article{Peng2024,
author = {Peng, Ying and Li, Zhonggen and Zhang, Jianchao and Dong, Yunshu and Zhang, Chenglin and Dong, Yiming and Zhai, Yafei and Zheng, Honglin and Liu, Mengduan and Zhao, Jing and Du, Wenting and Liu, Yangyang and Sun, Liping and Li, Xiaowei and Tao, Hailong and Long, Deyong and Zhao, Xiaoyan and Du, Xin and Ma, Changsheng and Wang, Yaohe and Dong, Jianzeng},
title = {Low‐Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.033700}
}
EUVIMED